5 completed. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 2 | Completed 2 |
Follow Pneumonia, Pneumococcal: new trials by email Literature Review of Pneumonia, Pneumococcal trials Research Report on Pneumonia, Pneumococcal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants AFX3772, Prevnar 13, Prevnar 20 - Pneumonia, Bacterial, Pneumococcal Infections | Phase 2 | Completed | GlaxoSmithKline | 388 | 2022-06-16 | 2026-10-09 |
| A Phase 1/Phase 2 Study of Polyvalent Pneumococcal Conjugate Vaccine (V116) in Adults (V116-001) V116, Pneumovax™23 - Pneumonia, Pneumococcal | Phase 1 / Phase 2 | Completed | Merck Sharp & Dohme LLC | 600 | 2019-12-06 | 2022-09-16 |
| Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae GEN-004 with Aluminum Hydroxide Adjuvant, Placebo, Streptococcus pneumoniae inoculation - Pneumococcal Infections, Pneumonia, Pneumococcal | Phase 2 | Completed | Genocea Biosciences, Inc. | 98 | 2014-09-01 | 2018-04-06 |
| Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers PATH-wSP, Synflorix, Pentavac - Pneumonia, Pneumococcal | Phase 1 / Phase 2 | Completed | PATH | 304 | 2014-04-01 | 2019-10-10 |
| Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients Sargramostim (GM-CSF), Pneumococcal Vaccine - Leukemia | Phase 2 | Completed | M.D. Anderson Cancer Center | 39 | 2004-06-01 | 2012-12-05 |
Pneumococcal Infections (2) · Pneumonia (2) · Infections (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Pneumonia, Bacterial (1) · Streptococcal Infections (1)
Bacterial Infections (5) · Bacterial Infections and Mycoses (5) · Gram-Positive Bacterial Infections (5) · Lung Diseases (5) · Respiratory Tract Diseases (5) · Respiratory Tract Infections (5) · Infections (4) · Pneumonia, Bacterial (4) · Streptococcal Infections (4) · Pneumococcal Infections (3) · Pneumonia (3) · Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1)
Sodium Chloride (2) · 10-valent pneumococcal conjugate vaccine (1) · 13-valent pneumococcal vaccine (1) · 23-valent pneumococcal capsular polysaccharide vaccine (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1) · Heptavalent Pneumococcal Conjugate Vaccine (1) · PHiD-CV vaccine (1) · Pentavac (1) · Pneumococcal Vaccines (1) · Saline Solution (1) · sargramostim (1)
Genocea Biosciences, Inc. (1) · GlaxoSmithKline (1) · M.D. Anderson Cancer Center (1) · Merck Sharp & Dohme LLC (1) · PATH (1)
United States (3) · Kenya (1) · Puerto Rico (1) · United Kingdom (1)
Amar Safdar, MD (1) · Nekoye Otsyula, MD (1) · Richard Fitzgerald, MD (1)
2014 (1), 2023 (1)